Spotlight -

Downstream Processing|

Upstream Processing

Prashant Pokhriyal

Prashant Pokhriyal is associate scientist at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Articles by Prashant Pokhriyal

Kateryna_Kon/Stock.adobe.com – The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

Do Modeling and Simulation Tools Really Benefit the Biosimilar Industry?

ByMili Pathak,Prashant Pokhriyal,Ronak Patel,Laxmi Adhikary

July 2nd 2022

The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

Using Modeling to Improve Data Analytics for Upstream Bioprocessing Workflows

ByPrashant Pokhriyal,Prateek Gupta,Sridevi Khambhampaty,Rajesh Ullanat,Mili Pathak

February 9th 2022

Recent trends in data analytics highlight the use of modeling techniques to improve process control and monitoring in biopharmaceutical production.

Sergey/Stock.Adobe.com—Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Recent Trends in Data Analytics for Upstream Process Workflows

ByPrashant Pokhriyal,Prateek Gupta,Sridevi Khambhampaty,Rajesh Ullanat,Mili Pathak

January 2nd 2022

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Latest Updated Articles

Recent Trends in Data Analytics for Upstream Process Workflows
Published: January 2nd 2022 | Updated:

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

© 2025 MJH Life Sciences^®

All rights reserved.